Android Apple

Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m

By Yahoo! Finance   |   2 months ago
Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m

Private equity firms hold the most power in Eliem Therapeutics with a 53% ownership stake, while institutions and hedge funds also have significant shares. The top 2 shareholders collectively control more than half of the company's shares.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.